ArticleFrontiers in oncology2022

MECOM/PRDM3 and PRDM16 Serve as Prognostic-Related Biomarkers and Are Correlated With Immune Cell Infiltration in Lung Adenocarcinoma.

Meng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.